第11章 市場預測

企業的市場佔有率

各市場部門

各地區

第12章 附錄

圖表

目錄

Product Code: GDME1117CFR

Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent grafts are designed to seal tightly with the patient's native artery above and below the aneurysm, and are used to treat abdominal aortic aneurysms as well as thoracic aortic aneurysms. Aortic aneurysms, as opposed to aneurysms found elsewhere in the body, are potentially very serious, as a burst aorta results in massive internal bleeding that can be fatal unless treated rapidly by an experienced emergency medical team. Since their introduction in patients in 1991, aortic stent graft devices have gained wide acceptance and availability, with their adoption fueled in great part by advances in stent-graft design and by a variety of devices for various anatomic features. Over time, these devices have gained traction for use in patients with ruptured aneurysms because they are minimally invasive and have shorter recovery times.

The EU market continues to be the second biggest market for aortic stent grafts at 23% of the global scene. Of this, Germany remains the leader as they are the pioneers of cardiovascular innovations and have a strong local manufacturing base. Similar to the US, the leading companies in the EU aortic stent grafts market are Medtronic, Cook Medical, and Gore Medical, with emerging players such as Endologix.

Scope

An overview of Aortic Stent Grafts, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.

Annualized the 5EU Aortic Stent Grafts market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020.

Investigation of current and future market competition for Aortic Stent Grafts.

Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.